News

If you're new to your scientific industry, it's time to learn an important part of what helps you gain more sponsors based on your research clout.

When the FDA Animal Rule, or Animal Efficacy Rule, became law in 2002, it created a pathway for assessing the safety and efficacy of drugs and biological products for “serious or life-threatening conditions caused by exposure to lethal or permanently disabling substances” when human clinical trials are not ethical or feasible.

Your lab is preparing to run a general toxicity study. You review the Good Laboratory Practices (GLPs) for the optimal tissue list. Brain is just one of the many required tissues, so what’s the big deal? Those histopathology folks will know what to do with it, right?

Pre-clinical Necropsy defines one of the processes researchers use to develop drugs for humans. It is a step taken using animals to study the tissue response to a developed drug.

Good Laboratory Practices (GLP) refers to a system where non-clinical health and safety studies are carried out, planned, monitored, recorded, archived and reported.

Conducting preclinical research is never easy. There are many components, and pathology is a big part of this. You need to explore the causes and effects of a particular disease, particularly how it affects the body. This will make it easier for you to proceed with your research and eventually learn enough so that you can take it to clinical studies.

As a laboratory that deals in a specific science, you're perhaps starting to realize it's impossible to do testing on your own without some help. Whether its histology, biotechnology, or the pharma industry, your reputation is on the line if a particular study goes awry due to staff inefficiencies.

Breast cancer is a serious disease that plagues both men and women around the globe. US Breast Cancer statistics estimates that approximately one in eight women will develop invasive breast cancer at some time in their life. There are approximately 240,000 new cases of invasive breast cancer and 61,000 cases of noninvasive breast cancer diagnosed every year. There is no cure for breast cancer as of yet, though there is a significant amount of research focused upon it.

The Histopathology industry is one that requires exacting study techniques and can suffer exponentially when not having enough capital expenditure. Studying disease and doing pre-clinical research means you have to set a high bar for your reputation, which could easily shatter with one mistake.

The efficiencies that contract research organizations can gain from outsourcing preclinical histopathology services comes from a mix of organizational principles and industry specific standards. Of these, the three most critical success factors to consider are the quality of the slides and data, the speed and accuracy of completion, and price competitiveness.